Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Cyclacel Pharmaceuticals Inc    

 SummaryChartsNewsCalendarCompanyFinancialsConsensus 
Company
Cyclacel Pharmaceuticals, Inc. is a diversified biopharmaceutical business focused in hematology and oncology based on a development pipeline of novel drug candidates.It is engaged in discovery, development and commercialization of novel, mechanism-targeted drugs to treat cancer and other serious... 
More about the company
Latest news on CYCLACEL PHARMACEUTICALS I
08/11 CYCLACEL PHARMACEUTICALS : Management's Discussion and Analysis of Financial Con..
08/10 CYCLACEL PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, ..
08/10 Cyclacel Pharmaceuticals Reports 2nd Quarter 2016 Financial Results
08/03 CYCLACEL PHARMACEUTICALS : Cyclacels CYC065 Demonstrates Promising Activity in U..
08/03 Cyclacel Pharmaceuticals to Release Second Quarter 2016 Financial Results
08/02 CYCLACEL PHARMACEUTICALS : CYC065 Demonstrates Promising Activity in Uterine Ser..
08/02 Cyclacel’s CYC065 Demonstrates Promising Activity in Uterine Serous Car..
07/13 CYCLACEL PHARMACEUTICALS INC : ex-dividend day
07/06 CYCLACEL PHARMACEUTICALS, INC. : Change in Directors or Principal Officers (form..
06/23 CYCLACEL PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Ter..
More news
Sector news : Bio Therapeutic Drugs
08/24DJAMGEN : FDA Rejects Amgen Hormonal-Imbalance Treatment
08/24DJAMGEN : FDA Rejects Amgen Hormonal-Imbalance Treatment
08/23DJDeal for Medivation Is the Latest In a Line of Similar Acquisitions -- WSJ
08/23DJPFIZER : to Acquire Key Drug -- WSJ
08/22DJPfizer's Medivation Deal Latest in Long Line of Similar Acquisitions
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
06/07 Midday Gainers / Losers
06/06 Midday Gainers / Losers
06/06 Cyclacel's lead product candidates show encouraging results in early-stage st..
06/06 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
06/02 Some Ideas For The Next Celator
Advertisement
Chart CYCLACEL PHARMACEUTICALS I
Duration : Period :
Cyclacel Pharmaceuticals I Technical Analysis Chart | US23254L3069 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Managers
NameTitle
Spiro Rombotis President, Chief Executive Officer & Director
David C. U'Prichard Chairman
Paul McBarron COO, CFO, Secretary, Director & Executive VP
David Glover Chief Scientist
John Michael Middlecott Banham Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CYCLACEL PHARMACEUTICA..7.17%22
AMGEN, INC.4.87%127 850
GILEAD SCIENCES, INC.-20.86%106 233
CELGENE CORPORATION-9.89%85 728
REGENERON PHARMACEUTIC..-26.27%42 671
VERTEX PHARMACEUTICALS..-23.40%23 963
More Results